Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
Journal of Infectious Diseases, :1-10
Lectura recomendada:
Preventing new Episodes of Bipolar Disorder in Adults: Systematic Review and Meta-analysis of Randomized Controlled Trials
European Neuropsychopharmacology, 54:75-89
Lectura recomendada:
Evaluation of a Multicomponent Intervention Consisting of Education and Feedback to Reduce Benzodiazepine Prescriptions by General Practitioners: The BENZORED Hybrid type 1 Cluster Randomized Controll
Plos One, 19(5):1-16
Lectura recomendada:
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Drug Safety, 44(12):1355-1364
Lectura recomendada:
Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence
Vascular Health and Risk Management, 17:591-600
Lectura recomendada:
Efficacy of Combination of Amlodipine (5MG) and Losartan (50MG) with Amlodipine (5MG) Monotherapy in Hypertensive Patients
International Journal of Medical and Biomedical Studies, 5(3):78-86
Lectura recomendada:
The Use of Vancomycin versus Teicoplanin in Treating Febrile Neutropenia: A Meta-Analysis and Systematic Review
Cureus, 13(5):1-14
En relación con el tratamiento centrado en la alfa sinucleína en la enfermedad de Parkinson (EP), señale la correcta.
Introducción:
La proteína alfa sinucleína se vincula con la enfermedad de Parkinson (EP). Las inclusiones de alfa sinucleína se detectan en la sustancia nigra de individuos con EP de tipo no familiar, y en la corteza cingulada y en la sustancia nigra de sujetos con demencia por cuerpos de Lewy, otro trastorno neurodegenerativo de las que se denominan sinucleinopatías.
Lectura recomendada:
Therapeutics in the Pipeline Targeting a-Synuclein for Parkinson’s Disease
Pharmacological Reviews, 74(1):207-237
Lectura recomendada:
Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial
Journal of Bone and Mineral Research, 37(7):1251-1259
Lectura recomendada:
Efficacy and Safety of Anti-Interleukin-5 Therapies in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
International Archives of Allergy and Immunology, 183(7):732-743
Lectura recomendada:
SGLT2i Versus ARNI in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Meta-analysis
ESC Heart Failure, 8(3):2210-2219
Lectura recomendada:
Tofacitinib and Risk of Malignancy: Results from the Safety of Tofacitinib in Routine Care Patients with Rheumatoid
Arthritis (STAR-RA) Study
Arthritis & Rheumatology, 74(10):1648-1659
Lectura recomendada:
Sodium-glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 diabetes: A Meta-analysis of Individual Participant Data from Randomized Controlled Trials
Circulation, 145(19):1460-1470
¿Cuál es la causa principal de osteoporosis secundaria?
Introducción:
El diagnóstico y el tratamiento de la osteoporosis secundaria es aún un desafío, ya que los individuos que la padecen (mujeres premenopáusicas y hombres jóvenes) no están habitualmente en los grupos a los que se dirige la pesquisa preventiva.
Lectura recomendada:
The Treatment Gap in Osteoporosis
Journal of Clinical Medicine, 10(13):1-13